Evaluation of clinical findings and neurofibromatosis type 1 bright objects on brain magnetic resonance images of 60 Turkish patients with NF1 gene variants
- 14 January 2021
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 42 (5), 2045-2057
- https://doi.org/10.1007/s10072-020-04988-0
Abstract
Neurofibromatosis type 1 (NF1) is caused by mutations in the NF1 gene. This retrospective study aims to evaluate the clinical manifestations and brain magnetic resonance images (MRI) analysis in 60 genetically confirmed NF1 patients. The results of next-generation sequencing (NGS), Sanger sequencing, and MLPA of NF1 gene were evaluated. A total of 54 different variants were identified. Fourteen out of them were novel variants (25.9%). Patients who complied with NIH criteria had most frequently frameshift variants (11/32 patients), and those with only CALMs had missense variants (9/28 patients). Neurofibromatosis type 1 bright objects (NBOs) on T2-weighted MRI were detected in 42 patients (42/56; 75%). These brain lesions were detected mostly in basal ganglia and in cerebellar vermis. NBOs were detected more in the patients who complied with NIH criteria (80.6%) compared to those who were only CALMs (68%). While frameshift variants (33.3%) were the most common type variants in the patients who had NBOs, the most common variants were splicing (35.7%) and missense (35.7%) variants in the patients whose MRIs were normal. Frameshift variants (11/28 patients; 39.3%) were the most common in the patients with more than one brain locus involvement. Therefore, we consider that frameshift variants may be associated with increased incidence of NBOs and involvement of more than one brain locus. In addition, NBOs may occur less frequently in the patients with splicing variants. To our knowledge, this is the first study evaluated the relationship between NF1 gene variants and NBOs. Future studies may help us understand the etiology of NBOs.Keywords
This publication has 48 references indexed in Scilit:
- Neurofibromatosis type 1: diagnosis and recent advancesExpert Opinion on Medical Diagnostics, 2010
- NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotypeHuman Mutation, 2010
- Clinical and genetic aspects of neurofibromatosis 1Genetics in Medicine, 2010
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithmNature Protocols, 2009
- Expression ofNF1pseudogenesHuman Mutation, 2005
- Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domainJournal of Medical Genetics, 2004
- Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 geneHuman Mutation, 2004
- Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patientsJournal of Medical Genetics, 2003
- Elevated Risk for MPNST in NF1 Microdeletion PatientsAmerican Journal of Human Genetics, 2003
- cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene productGenomics, 1991